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Treatment of the 3-monomethanesulfonates of 1,2,2-trisubstituted
1,3-propanediols under phase-transfer conditions affords 2-aryl (or
alkyl)-3,3-dialkyloxetanes. Twelve oxetanes have been obtained by
this method; three of these oxetanes have been obtained enantio-
merically pure as both enantiomers starting from the appropriate
enantiomerically pure 1,3-diols. In these reactions the chiral center
does not undergo inversion and the oxetanes have the same absolute
configuration as the starting 1,3-diols.
The development of various ring-opening and ring-ex-
pansion strategies has increased the synthetic accessibility
of oxetanes. This, together with some commercial suc-
cesses in polymers, pharmaceuticals and agrochemicals
has led to renewed interest in these ring systems.1 - 14
Oxetanes are often synthesized from 1,3-diols by treat-
ment of their methanesulfonates or toluenesulfonates un-
der alkaline conditions (sodium hydride, potassium tert-
butoxide, butyllithium, etc.) in organic solvents (Scheme
1).15 - 17 This method suffers sometimes, however, from
low yields as well as the need for expensive alkaline rea-
gents, which makes the procedure less attractive to apply,
particularly in an industrial setting.
Scheme 1
Trisubstituted 1,3-propanediols are easily obtained from
an aldol condensation followed by a cross Cannizzaro
reaction when two equivalents of isobutyraldehyde (or
another a,a-disubstituted aliphatic aldehyde) and a sub-
stituted benzaldehyde (or in some cases an aliphatic al-
dehyde) are  allowed  to  react  under  basic  conditions  in
alcoholic solvents.18 - 19 These 1,3-diols are interesting in
that they are readily converted to phosphoric acid
derivatives on reaction with phosphorous oxychloride
followed by base. These phosphoric acids have been re-
solved by ten Hoeve and Wynberg.20 The enantiomeri-
cally pure 1,3-diols can be readily obtained by treatment
of the phosphoric acids with glycol and potassium hy-
droxide or with lithium aluminum hydride (Scheme 2).21
There has been considerable interest in using these enan-
tiomerically pure 1,3-diols as chiral synthons or chiral
auxiliaries. 22 - 23
Synthesis and stereochemical characterization of both
racemic and optically pure oxetanes from these 1,3-diols
was the aim of this work.
Reaction of the diols 1a-i, obtained as indicated in
Scheme 2, with methanesulfonyl chloride at -10 to 0°C in
the presence of triethylamine or pyridine in dichloro-
methane or chloroform gave the sensitive monomethane-
sulfonates 2a-i, which could be characterized by NMR
techniques. There is ample precedent for mesylation (or
tosylation) at the least hindered primary hydroxy
group.24 - 28 This structural assignment is also entirely
consistent with the 1H NMR spectrum. For 2a the ben-
zylic proton, which is diagnostic for functionalization at
the secondary hydroxy group, absorbs at d = 4.65 and is
barely shifted relative to the free diol 1a in which this
absorption is found at d = 4.62. The diastereotopic pro-
tons of the methylene group are, however, shifted down-
field in 2a. In the dimesylate 5, obtained by mesylation
with excess mesyl chloride under forcing conditions, the
ben ylic proton is shifted downfield to d = 5.50 indicative
of mesylation at this position. The conversions are illus-
trated for the series a in Scheme 4. No evidence (NMR)
was ever obtained for competing sulfonation at the sec-
ondary alcohol position.
Scheme 2 Scheme 3
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Ring closure is accomplished under basic conditions in
a Williamson reaction whereby the secondary alcohol
acts as the nucleophile. Phase transfer catalysis (PTC)
offers significant advantages over conventional proce-
dures for ionic substitution processes.29 Th  avoidance
of expensive anhydrous or aprotic solvents, the use of
cheap, aqueous bases, improved reaction rates, lower
reaction temperatures, and easier workup are all advan-
tages that accrue to the method. Application of PTC
methods (quaternary ammonium salt, NaOH as base,
CH2Cl2 as solvent) led to the formation of 3a-i (Scheme













g R1 =R2 =CH3, R
3 =2-CH3OC6H4, (92 %);
h R1 =R2 =CH3, R
3 =4-CH3OC6H4, (93 %);
i R1 =R2 =CH3, R
3 =2-CH2CH3OC6H4, (91 %);
j R1 =R2 =CH3, R
3 =CHMe2, (95 %);
k R1 =R2 =CH3, R
3 =Thienyl, (85 %);
l R1 =R2 =Cyclohexylidine, R3 =C6H5, (87 %);
Scheme 4
Compound 3a has been reported in the literature15 nd
was prepared in 82 % yield from the mesylate of 1a by
treatment with KOBu-t in tert-butyl alcohol following the
literature method. Attempts by us (entries 2 and 3 in
Table 1) to use cheaper KOH in MeOH led to signi-
ficantly poorer yields. The 2-methyl-1-phenylprop-1-ene
found (entry 3) appears to be the result of a catalyzed
thermolysis of mesylate 2  or oxetane 3a at 50°C. The
pure oxetanes are, however, thermally stable at this tem-
perature and begin to undergo thermal cycloreversion
and/or polymerization only at about 300°C.30 Oxetane
thermolysis is complicated and is known to be subject to
acid catalysis.31,32 On distillation of impure 3a contain-
ing  a very small amount of mesylate (monomesylate or
dimesylate) some  2-methyl-1-phenylprop-1-ene  was  ob-
Table 1.Ring Closure of 2a Under Various Conditions to Give
Compound 3a (Scheme 5).
Entry Reaction conditions Yield (%)
1 t-BuOH/t-BuOK, r.t., 20 h 82
2 KOH/MeOH, r.t., 20 h 51
3 KOH/MeOH, 50°C/1 h and then r.t./10 h55a
4 PTC, CH2Cl2/H2O/NaOH, r.t./2-4 h > 95
a  2-Methyl-1-phenylprop-1-ene formed in 38% yield.
served, apparently the result of catalyzed decomposition.
The oxetanes were therefore first subjected to column
chromatography followed by distillation to obtain ana-
lytically pure materials.
The choice of leaving group is important. The tosylate
of 1a under comparable PTC conditions required a reac-
tion time of five days at room temperature to obtain a
yield of 3a of 50 % whereas 2a provided the oxetane in
> 95 % yield in 2-4 hours under analogous conditions
(Scheme 5).
Scheme 5
Several quaternary ammonium salts were examined as
phase transfer catalysts under given conditions for the
synthesis of 3a from 2a (Table 2). Bu4NHSO4 is clearly
the best catalyst among these quaternary ammonium salts
although Bu4NBr, Bu4NF and (n-C8H17)3MeNCl are
also acceptable under the conditions used.
Table 2. Influence of PTCa on the Ring Closure of 2a (Scheme 5).
Entry PTC Resultsb, c
1 Bu4NBr + +
2 Bu4NI +
3 Bu4NF + +




8 (n-C8H17)3NMeCl + +
9 No PTC –
a R acti  condition: monomesylate 2a (1 g), CH2Cl2 (30 mL),
10% aq NaOH (15 mL), PTC (1 mol%), stirring at r.t.
b The conversion of reactants was followed by NMR.
c –, Very slow, conversion about 35 % after stirring for 5 d;
+, some reaction, conversion about 65 % after stirring for 2 d;
+ +, good, conversion about 80 % after stirring for 18 h;
+ + +,   very good, conversion about 97 %  after stirring for 8 h.
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There is a roughly linear relation (at least in the initial
stages) between the concentration of alkali and the reac-
tion rate under standard conditions (Figure 1). Mesylate
2a was converted to oxetane within 3-4 hours when
50 % aqueous sodium hydroxide was used but the reac-
tion took nearly one day when 10 % aqueous sodium
hydroxide was used.
Influence of Concentration of NaOH
  * Reaction condition: monomesylate 2a (1g), CH2Cl2 (20ml), NaOH in
water (10ml), PTC (1%mol), stirring at the room temperature.
** Detected by NMR, the conversion of monomesylate 2a was followed.
Figure 1
In phase transfer catalysis, the effect of counterions can
be pronounced. In initial experiments, crude mesylates
were used without purification for the ring-closure reac-
tions in an attempt to carry out a one-pot procedure. As
shown in Figure 2, however, extraction of the crude me-
sylate 2a, dissolved in CH2Cl2, with H2O prior to reac-
tion leads to a substantial increase in reaction rate. This
is most likely due to the removal of Et3NH
+, Cl- from the
mesylate. This extra ionic material suppresses the rate of
ring closure. A washing procedure was used consistntly
once this effect had been uncovered.
Influence of Washing with Water for PTC
* Reaction condition: monomesylate 2a (10mmol), CH2Cl2 (50ml),
10% NaOH (20ml), PTC (1%mol), stirring at room temperatue.
** Detected by NMR, the conversion of monomesylate 2a was followed.
Figure 2
Table 3. Absolute [a]20578 of Optically Pure Oxetanesa
Compound Absolute [a]578 (c) (CHCl3)
(S)-( + )-3a +122.6 (0.45)
(R)-( – )-3a –124.4 (0.45)
(S)-( – )-3c –155.5 (0.38)
(R)-( + )-3c +157.6 (0.42)
(S)-( – )-3g –173.5 (0.37)
(R)-( + )-3g +171.8 (0.38)
a The enantiomeric purity of the oxetanes was determined by 1H
NMR (200 MHz) analysis using the chiral shift reagent tris(d,d-
dicampholylmethanato)europium(III), Eu(dcm)3, 10 mol %.
Optically active 3,3-dimethyl-2-phenyl-oxetane (S)-( + )-
3a has been synthesized previously by means of enan-
tioselective reduction of 3-chloro-2,2-dimethyl-1-phenyl-
1-propanone followed by ring closure.33 In this work as
well as that of Balsamo et al.15 it has been shown that
the chiral center of starting substance  (1,2-disubstituted
1,3-diols or 1,2-disubstituted 3-chloropropanols) is not
involved in the ring closure and keeps its original confi-
guration. The diols 1a, 1c and 1g in optically pure R
and S forms were readily converted into the optically
pure oxetanes (Figure 3) by the PTC procedure described
above. The configuration of the asymmetric center is not
affected during reaction. Optical rotations of the products
are given in Table 3. Optically pure (S)-( + )-3a has an
absolute rotation of [a]D +113.8°, which agrees with
literature data33 [for (S)-( + )-3a of 89 % ee an [a]D
+100.1° was found, corresponding to [a]D +112.5° for
optically pure material].
Figure 3
All chemicals used in this work were commercially available. The
1,3-diols including optically pure samples were prepared following
literature methods.20 (S)-( - )-2-Hydroxy-4-(2-methoxyphenyl)-5,5-
dimethyl-1,3,2-dioxaphosphorinane 2-oxide was generously
supplied by Dr. R. Hulst. 1-Isopropyl-2,2-dimethyl-1,3-propanediol
was bought from Janssen as were all of the quaternary ammonium
salts used as phase transfer catalysts. Methanesulfonyl chloride
should be used from a fresh bottle. 1H NMR (200 MHz) and
13C NMR (50.3 MHz) spectra were determined on a Varian Gemini-
200 system. CDCl3 was used as a solvent and Me4Si as an internal
reference. The enantiomeric purities of the oxetanes were determin-
ed by 1H NMR (200 MHz) analysis using the chiral shift reagent
tris(dicampholylmethanato)europium(III), Eu(dcm)3, 10 mol per-
cent. In all cases the racemic mixtures were examined to ascertain
whether the enantiomers could be discriminated. Accuracy is about
5 %. IR spectra were obtained in KBr  pellets  with  a  Perkin-Elmer
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781 spectrometer. Mass spectra were recorded on an AEI-MS902
mass spectrometer at 70 eV. All mps were determined on a Mettler
FP1 melting apparatus and are uncorrected. Optical rotations were
measured with a Perkin-Elmer Model 241 polarimeter at room
temperature.
2,3-Substituted Oxetanes from 1,2-Substituted 1,3-Propanediols;
General Procedure:
To a stirred solution of diol (0.1 mol) and dry Et3N (0.12 mol) in
CH2Cl2 (150 mL) at 0°C was added dropwise a solution of methane-
sulfonyl chloride (0.105 mol) in CH2Cl2 (50 mL). The mixture was
stirred at 0°C for 30 min after the addition, then allowed to warm to
r.t. and was stirred for a further 1 h. The mixture was washed with
200 mL of water. A small sample of monomethanesulfonate was
obtained for characterization by drying and evaporation of a part of
the organic phase. This was examined by NMR and infrared
spectroscopy. In view of the sensitivity, no attempts were made to
purify these intermediates further except 2a, which was crystallized
by slow evaporation of solvent (CH2Cl2).
The organic phase was placed in a flask after separation of water.
The phase transfer catalyst (PTC) (1-3 mol%) and 50 % aq NaOH
(60 mL) was added. The mixture was stirred for 2-4 h at r.t. No
monomethanesulfonate could be detected by TLC (aluminum oxide,
Et2O as eluant). The reaction was stopped and was worked up. The
organic phase was separated and dried (MgSO4). The solution was
filtered and evaporated with a rotatory evaporator under reduced
pressure. The residue was separated by column chromatograp y
(aluminum oxide; Et2O).
34 The pure oxetanes were obtained by
bulb-to-bulb distillation under reduced pressure.
1,3-Dimethanesulfonyloxy-2,2-dimethyl-1-phenylpropane (5):35
To a stirred solution of 2,2-dimethyl-1-phenyl-1,3-propanediol
(10 g, 55.6 mmol) in dry Et3N (25 mL) and CH2Cl2 (100 mL) at 0°C
was slowly added dropwise methanesulfonyl chloride (13 mL,
167 mmol). The mixture was stirred at 0°C for 30 min after the
addition, then was stirred overnight at reflux temperature under a
nitrogen atmosphere. The reaction mixture was poured into 150 mL
of ice-water. The oil was extracted with CHCl3 (´ 3) and dried
(MgSO4). Evaporation of the solvent gave the product 5, which was
crystallized from Et2O (17.0 g, 50.6 mmol, 91 % yield, mp:
83-86°C).
1H NMR (CDCl3): d = 0.95 (s, 3H), 1.08 (s, 3 H), 2.65 (s, 3H),
3.07 (s, 3H), 3.92 (d, 2J = 9.4 Hz, 1 H), 4.17 (d, 2J = 9.4 Hz, 1 H),
5.51 (s, 1H), 7.39 (m, 5 H).
13C NMR (CDCl3): d = 19.11 (q), 21.04 (q), 37.18 (q), 39.12 (q),
39.30 (s), 74.16 (t), 86.09 (d), 127.92 (d), 128.50 (d), 29.19 (d),
134.55 (s).
IR (KBr): n = 3425br w, 3038s, 3023s, 2985s, 2943s, 1472s, 1452s,
1345br vs, 1185vs, 968br vs, 842vs, 748s, 705s cm-1.
3,3-Dimethyl-2-phenyloxetane (3a) from 2,2-Dimethyl-1-phenyl-1,3-
propanediol (1a) by Reaction of the Monomethanesulfonate with
Potassium tert-Butoxide in tert-Butyl Alcohol:
A solution of the monomethanesulfonate 2a (10 g, 55.6 mmol) in
t-BuOH (120 mL) was treated with KOBu-t (7 g, 62.5 mmol) and
was stored overnight at r.t. The reaction mixture was diluted with
petroleum ether and filtered. Evaporation of the solvent gave a
residue, which was washed with 30 mL of water and dried (MgSO4).
Filtration and evaporation gave crude oxetane (7.9 g). The crude
product was separated by column chromatography (aluminum oxi-
de; Et2O) to yield 7.4 g (45.7 mmol, 82 %) of 3a.
Reaction of 3-Methanesulfonyloxy-2,2-dimethyl-1-phenyl-1-propanol
(2a) with Sodium Hydroxide (or Potassium Hydroxide) in Methanol:
The monomethanesulfonate 2a (4 g, 15.5 mmol) was treated with
KOH (3 g, 54 mmol) in MeOH (10 mL) and was left overnight at r.t.
Isolation of the mixture gave 1.4 g (56 %) of 3,3-dimethyl-2-
phenyloxetane and 1.7 g of starting monomethanesulfonate.
The monomethanesulfonate of 2,2-dimethyl-1-phenyl-1,3-propane-
diol (4 g, 15.5 mmol) was treated with KOH (3 g, 54 mmol) in
MeOH (15 mL) and stirred for 1 h at 50°C, and then stored over-
night  at  r.t. The  results  of  NMR  measurements  showed  that  the
mixture contained 2-methyl-1-phenylprop-1-ene (38 %) and 3,3-di-




1H NMR (CDCl3): d = 0.91 (s, 3H), 0.93 (s, 3 H), 2.21 (s, 1 H),
3.02 (s, 3 H), 3.90 (s, 3 H), 3.92 (d, 2J  = 9.3 Hz, 1 H), 4.34 (d,
2J  = 9.3 Hz, 1 H), 4.65 (s, 1 H), 7.32 (t, 5 H).
13C NMR (CDCl3): d = 18.34 (q), 21.47 (q), 36.89 (q), 39.70 (s),
76.13 (t), 76.58 (d), 127.61 (d), 127.76 (d), 127.84 (d), 140.07 (s).
IR (KBr): n = 3539br s, 3029m, 2976s, 1474s, 1452s, 1350vs,
1172vs, 1048s, 957vs, 831s, 737s, 705s cm-1.
3,3-Dimethyl-2-phenyloxetane (3a):32
1H NMR (CDCl3): d = 0.82 (s, 3 H), 1.42 (s, 3H), 4.28 (d,
2J  = 5.4 Hz, 1 H), 4.55 (d, 2J = 5.4 Hz, 1 H), 5.54 (s, 1 H), 7.33 (m,
5 H).
13C NMR (CDCl3): d = 22.41 (q), 26.89 (q), 40.25 (s), 81.24 (t),
91.72 (d), 125.06 (d), 127.25 (d), 128.08 (d), 140.00 (s).
IR (KBr): n = 3440brw, 3061w, 3027w, 2958vs, 1721m, 1461m,
1271m, 982vs, 741s, 700s cm-1.
Exact mass for C11H14O requires: M, 162.104; found: M
+, 162.104.
2,2-Dimethyl-1-phenyl-3-toluenesulfonyloxy-1-propanol (4):
1H NMR (CDCl3): d = 0.81 (s, 3H), 0.85 (s, 3 H), 2.49 (s, 3 H),
3.51 (2d, 2H), 3.92 (br, 3 H, H2O), 4.62 (s, 1 H), 7.31-7.94 (m,
9 H).
13C NMR (CDCl3): d = 18.84 (q), 22.73 (q), 39.02 (s), 71.97 (t),
82.02 (d), 127.00 (d), 127.44 (d), 127.58 (d), 127.67 (d), 127.92 (d),
130.22 (d), 141.44 (s), 146.80 (s), 157.90 (s).
IR (KBr): n = 3412br s, 3065m, 3031m, 2971s, 2877m, 1595m,
1453s, 1371br s, 1173vs, 1043s, 966s, 814s, 704s cm-1.
1-(2-Fluorophenyl)-3-methanesulfonyloxy-2,2-dimethyl-1-propanol
(2b):
1H NMR (CDCl3): d = 0.90 (s, 6H), 2.86 (br, 1 H), 3.00 (s, 3 H),
3.94 (d, 2J  = 9.3 Hz, 1 H), 4.34 (d, 2J = 9.3 Hz, 1 H), 5.00 (s, 1 H),
7.23 (m, 4 H).
13C NMR (CDCl3): n = 17.97 (q), 21.06 (q), 36.84 (q), 39.95 (s),
69.27 (d), 75.82 (t), 114.79 (d), 115.26 (d), 123.76 (d), 129.32 (d),
157.37 (s), 162.23 (s).
IR (KBr): n = 3536br s, 2972s, 1600s, 1586m 1490s, 1465s, 1440s,
1350vs, 1286m, 1241s, 1173vs, 1042s, 955s, 852m, 833m,
759s cm-1
2-(2-Fluorophenyl)-3,3-dimethyloxetane (3b):
1H NMR (CDCl3): d = 0.86 (s, 3 H), 1.45 (s, 3H), 4.25 (d,
2J  = 5.4 Hz, 1 H), 4.54 (d, 2J  = 5.4 Hz, 1 H), 5.74 (s, 1 H), 6.95-7.64
(m, 4 H).
13C NMR (CDCl3): d = 22.10q, 26.20q, 40.18s, 81.35s, 86.70d,
114.24d, 124.05d, 126.94d, 128.50d, 156.64s, 161.65s.
IR (KBr): n = 3432br w, 3070w, 2963m, 2932m, 1714s, 1612s,
1487s, 1456s, 1307s, 1228s, 1129s, 1085s, 757s cm-1.





1H NMR (CDCl3): d = 0.95 (s, 3H), 0.96 (s, 3 H), 3.04 (s, 3 H),
3.99 (d, 2J  = 9.3 Hz, 1 H), 4.40 (d, 2J = 9.3 Hz, 1 H), 5.25 (s, 1 H),
7.24-7.32 (m, 4 H).
13C NMR (CDCl3): d = 18.05q, 21.22q, 37.00q, 40.68s, 71.33d,
75.82t, 126.46d, 128.77d, 129.33d, 129.76d, 133.28s, 138.56s.
IR (KBr): n = 3535br s, 3027w, 2973s, 1472s, 1439s, 1350vs,
1174vs, 1030s, 957vs, 851s, 832s, 754s cm-1.
2-(2-Chlorophenyl)-3,3-dimethyloxetane (3c):
1H NMR (CDCl3): d = 0.85 (s, 3 H), 1.57 (s, 3H), 4.29 (d,
2J  = 5.4 Hz, 1 H), 4.52 (d, 2J  = 5.4 Hz, 1 H), 5.78 (s, 1 H), 7.16-7.74
(m, 4 H).
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13C NMR (CDCl3): d = 22.03q, 26.93q, 40.33s, 81.24t, 89.00d,
126.74d, 127.28d, 128.17d, 128.84d, 130.80s, 138.03s.
IR (KBr): n = 3437brw, 3069w, 2965s, 2871s, 1730s, 1462s, 1439s,
1295s, 1246s, 1124s, 1052s, 987s, 750vs cm-1





1H NMR (CDCl3): d = 0.87 (s, 3H), 0.89 (s, 3 H), 3.03 (s, 3 H),
3.88 (d, 2J  = 9.4 Hz, 1 H), 4.33 (d, 2J = 9.4 Hz, 1 H), 4.63 (s, 1 H),
7.26 (d, 3J  = 3.0 Hz, 2 H), 7.31 (d, 3J  = 2.6 Hz, 2 H).
13C NMR (CDCl3): d = 18.09q, 21.45q, 36.94q, 39.36s, 75.67d,
75.94t, 127.95d, 128.97d, 133.41 s, 139.12s.
IR (KBr): n = 3546br s, 3025w, 2981m, 2840m, 2882m, 1487m,
1473m, 1343vs, 1169vs, 1091m, 1060s, 1012s, 975s, 957vs, 866s,
833s, 770m cm-1.
2-(4-Chlorophenyl)-3,3-dimethyloxetane (3d):32
1H NMR (CDCl3): d = 0.78 (s, 3 H), 1.39 (s, 3H), 4.24 (d,
2J  = 5.5 Hz, 1 H), 4.52 (d, 2J = 5.5 Hz, 1 H), 5.46 (s, 1 H), 7.23 (d,
3J= 8.0 Hz, 2 H), 7.31 (d, 3J= 8.4 Hz, 2 H).
13C NMR (CDCl3): d = 22.37q, 26.79q, 40.04s, 81.21t, 91.04d,
126.45d, 128.27d, 132.13s, 138.71s.
IR (KBr): n = 3465w, 2967m, 2942m, 1490m, 1351vs, 1176vs,
1089m, 1009s, 972s, 920s, 812m cm-1.





1H NMR (CDCl3): d = 0.94 (s, 6H), 2.67 (s, 1 H), 3.00 (s, 3 H),
3.96 (d, 2J  = 9.3 Hz, 1 H), 4.36 (d, 2J = 9.3 Hz, 1 H), 5.19 (s, 1 H),
7.07-7.54 (m, 4 H).
13C NMR (CDCl3): d = 18.06q, 21.39q, 36.98q, 40.78t, 73.64d,
75.82d, 123.86s, 127.12d, 129.16d, 129.98d, 132.68d, 140.14s.
IR (KBr): n = 3536br s, 2973s, 1467s, 1353vs, 1175vs, 956brs,
852s, 830s, 751s cm-1.
2-(2-Bromophenyl)-3,3-dimethyloxetane (3e):
1H NMR (CDCl3): d = 0.84 (s, 3 H), 1.61 (s, 3H), 4.30 (d,
2J  = 5.4 Hz, 1 H), 4.49 (d, 2J  = 5.4 Hz, 1 H), 5.72 (s, 1 H), 7.10-7.73
(m, 4 H).
13C NMR (CDCl3): d = 22.12q, 27.30q, 40.33s, 81.30t, 90.52d,
120.72s, 127.29d, 127.76d, 128.55d, 132.14d, 140.04s.
IR (KBr): n = 3425brw, 3064w, 2965s, 2871s, 1732m, 1465s,
1436s, 1242m, 1117m, 1028s, 986vs, 750s cm-1.





1H NMR (CDCl3): d = 0.87 (s, 3H), 8.89 (s, 3 H), 3.06 (s, 3 H),
3.16 (s, 1H), 3.88 (d, 2J = 9.4 Hz, 1 H), 4.39 (d, 2J = 9.4 Hz, 1 H),
4.77 (s, 1H), 7.50 (d, 3J = 8.8 Hz, 2 H), 8.15 (d, 3J = 8.8 Hz, 2 H).
13C NMR (CDCl3): d = 17.90q, 21.59q, 37.03q, 39.54s, 75.16d,
75.65t, 122.84d, 128.59d, 147.30s, 148.35s.
IR (KBr): n = 3528brm, 3027w, 2975m, 1603m, 1517s, 1345vs,
1172vs, 1056m, 957vs, 856s, 738m.
3,3-Dimethyl-2-(4-nitrophenyl)oxetane (3f):
1H NMR (CDCl3): d = 0.77 (s, 3 H), 1.43 (s, 3H), 4.26 (d,
2J  = 5.6 Hz, 1 H), 4.55 (d, 2J = 5.6 Hz, 1 H), 5.56 (s, 1 H), 7.44 (d,
3J  = 8.2 Hz, 2 H), 8.22 (d, 3J  = 8.8 Hz, 2 H).
13C NMR (CDCl3): d = 22.47q, 26.80q, 40.95s, 81.34t, 90.49d,
123.45d, 125.71d, 147.20s, 147.85s.
IR (KBr): n = 3078w, 2959s, 2873s, 1604s, 1526vs, 1462s, 1343vs,
1104s, 1007s, 985vs, 868s, 849s, 743s, 701s cm-1.





1H NMR (CDCl3): d = 0.88 (s, 3H), 0.90 (s, 3 H), 2.97 (s, 3 H),
3.39 (s, 1 H), 3.78 (s, 3 H), 3.96 (d, 2J = 9.12 Hz, 1 H), 4.27 (d,
2J  = 9.59 Hz, 1 H), 4.92 (d, 1 H), 6.82-7.39 (m, 4 H).
13C NMR (CDCl3): d = 17,72q, 21.17q, 45.81s, 72.23d, 76.45t,
110.55d, 1120.29d, 128.56d, 129.32d, 156.80s.
IR (KBr): n = 3534brs, 3022w, 2976s, 1613m, 1586m, 1486s,
1453s, 1352vs, 1221s, 1172vs, 1048s, 954vs, 803s, 761s cm-1.
2-(2-Methoxyphenyl)-3,3-dimethyloxetane (3g):
1H NMR (CDCl3): d = 0.80 (s, 3H), 1.44 (s, 3 H), 3.77 (s, 3 H),
4.22 (d, 2J  = 5.3 Hz, 1 H), 4.51 (d, 2J = 5.3 Hz, 1 H), 5.72 (s, 1 H),
6.80-7.56 (m, 4 H).
13C NMR (CDCl3): d = 22.01q, 26.49q, 40.02s, 81.21t, 88.14q,
109.23d, 120.39d, 125.86d, 127.73d, 129.18s, 155.69s.
IR (KBr): n = 3523brw, 2965s, 1694m, 1599m, 1489s, 1463s,
1353s, 1240vs, 1176s, 1085s, 1027s, 1010s, 972s, 920s, 765s cm-1





1H NMR (CDCl3): d = 0.83 (s, 3H), 0.87 (s, 3 H), 2.97 (s, 3 H),
3.75 (s, 3H), 3.87 (d, 2J = 9.2 Hz, 1 H), 4.26 (d, 2J = 9.2 Hz, 1 H),
4.54 (s, 1H), 6.81 (d, 3J = 8.7 Hz, 2 H), 7.18 (d, 3J = 8.6 Hz, 2 H).
13C NMR (CDCl3): d = 18.34q, 21.39q, 36.78q, 39.39s, 55.19q,
76.09d, 76.34t, 113.13d, 128.68d, 132.78s, 159.20s.
IR (KBr): n = 3536brs, 2970m, 2937m, 1609m, 1513s, 1464m,
1351vs, 1247s, 1112vs, 1030s, 954vs, 836s cm-1.
2-(4-Methoxyphenyl)-3,3-dimethyloxetane (3h):32
1H NMR (CDCl3): d = 0.87 (s, 3H), 1.45 (s, 3 H), 3.88 (s, 3 H),
4.32 (d, 2J  = 5.13 Hz), 1 H), 4.58 (d, 2J = 5.55 Hz, 1 H), 5.53 (s,
1 H), 6.99 (d, 3J = 8.6 Hz, 2 H), 7.31 (d, 3J  = 9.0 Hz, 2 H).
13C NMR (CDCl3): d = 22.16q, 26.63q, 40.28s, 54.97d, 80.93t,
91.46q, 113.40d, 126.25d, 132.15s, 158.71s.
IR (KBr): n = 2958s, 2869m, 1612m, 1511s, 1461m, 1247vs, 1169s,
1034s, 980s, 839m c -1.





1H NMR (CDCl3): d = 0.91 (s, 3H), 0.93 (s, 3 H), 1.41 (t, 2 H),
2.99 (s, 3 H), 3.21 (br, 1 H), 3.99 (d, 2J  = 9.3 Hz, 1 H), 4.30 (d,
2J  = 9.3 Hz, 1 H), 4.92 (d, 1 H), 6.82-7.29 (m, 4 H).
13C NMR (CDCl3): d = 14.76q, 18.83q, 21.33q, 36.84q, 40.53s,
63.44t, 73.12d, 76.38t, 111.27d, 120.18d, 128.11s, 128.55d,
129.49d, 156.20s.
IR (KBr): n = 3541br m, 3067w, 2980m, 2937m, 1599m, 1490m,
1475m, 1452m, 1352vs, 1240s, 1147vs, 1044s, 954vs, 854m, 832,
757m cm-1.
2-(2- Ethoxyphenyl)-3,3-dimethyloxetane (3i):
1H NMR (CDCl3): d = 0.83 (s, 3H), 1.41 (t, 3 H), 1.476 (s, 3 H),
4.01 (m, 2H), 4.24 (d, 2J = 5.2 Hz, 1 H), 4.53 (d, 2J = 5.2 Hz, 1 H),
5.76 (s, 1H), 6.79-7.58 (m, 4 H).
13C NMR (CDCl3): d = 14.88q, 22.06q, 26.56q, 39.92s, 63.02t,
81.24t, 88.32d, 109.86d, 120.21d, 125.89d, 127.70d, 129.19s,
155.09s.
IR (KBr): n = 3069w, 3041w, 2963s, 2928s, 2869s, 1600m, 1490s,
1476m, 1453s, 1283m, 1245vs, 1119s, 1045s, 984s, 753s cm-1.




1H NMR (CDCl3): d = 0.90-1.00 (q, 12H), 1.96 (m, 2 H), 3.00 (s,
3 H), 3.33 (d, 1 H), 3.84 (d, 2J = 9.2 Hz, 1 H), 4.22 (d, 2J = 9.2 Hz,
1 H).
538 Papers SYNTHESIS
13C NMR (CDCl3): d = 16.84q, 18.97q, 21.93q, 23.32q, 28.56d,
36.88q, 39.54s, 76.82t, 77.81d.
IR (KBr): n = 3551br, s, 3016m, 2967s, 1469m, 1341vs, 1169vs,
981s, 969s, 950vs, 858m, 749m cm-1.
2-Isopropyl-3,3-dimethyloxetane (3j):36
1H NMR (CDCl3): d = 0.70 (d, 3J  = 6.51 Hz, 3 H), 0.84 (d,
3J  = 6.51 Hz, 3 H), 1.15 (d, 3 H), 1.20 (d, 3 H), 1.94 (m, 1 H), 3.88
(d, 2J  = 10.5 Hz, 1 H), 3.9 (d, 2J  = 5.2 Hz, 1 H), 4.24 (d, 2J  =
5.27 Hz, 1 H).
13C NMR (CDCl3): d = 17.04q, 17.77q, 20.82q, 20.82q, 26.66q,
30.05d, 38.30t, 79.81s, 95.87d.
IR (KBr): n = 3431brw, 2956vs, 2928vs, 2872vs, 1732w, 1699w,
1469s, 1388m, 1370m, 1034m, 982s, 936m, 854w c -1.
Exact mass for C8H16O requires: M, 128.120; found: M
+,128.120.
3-Methanesulfonyloxy-2,2-dimethyl-1-(2-thienyl)-1-propanol (2k):
1H NMR (CDCl3): d = 0.93 (s, 3H), 0.99 (s, 3 H), 2.98 (s, 3 H),
3.91 (d, 2J  = 9.2 Hz, 1 H), 4.26 (d, 2J = 9.2 Hz, 1 H), 4.88 (d, 2 H),
6.92-7.27 (m, 3 H).
13C NMR (CDCl3): d = 18.59q, 21.27q, 36.82q, 39.35s, 73.16d,
75.97t, 124.71d, 125.64d, 126.35d, 144.32s.
IR (KBr): n = 3529br m, 3072w, 2938m, 1472m, 1349vs, 1174vs,
956vs, 843s, 709s cm-1.
3,3-Dimethyl-2-(2-thienyl)oxetane (3k):
1H NMR (CDCl3): d = 0.98 (s, 3 H), 1.38 (s, 3H), 4.32 (d,
2J  = 5.5 Hz, 1 H), 4.47 (d, 2J  = 5.5 Hz, 1 H), 5.66 (s, 1 H), 6.94-7.31
(m, 3 H).
13C NMR (CDCl3): d = 22.15q, 26.52q, 41.09s, 81.28d, 88.75d,
123.51d, 124.62d, 126.83d, 143.82s.
IR (KBr): n = 3483brw, 3104w, 3071w, 2969s, 2933s, 1721m,
1669m, 1472s, 1361s, 1090vs, 1041s, 856m, 833m, 696scm-1.
Exact mass for C9H12SO requires: M, 168.061; found: M
+,168.061.
a-(1-Methanesulfonyloxymethyl-1-cyclohexyl)benzyl Alcohol (2l):
1H NMR (CDCl3): d = 1.05-1.57 (m, 10 H), 2.97 (s, 3 H), 4.16 (d,
2J  = 9.6 Hz, 1 H), 4.39 (d, 2J  = 9.6 Hz, 1 H), 4.66 (s, 1 H), 7.25-7.39
(m, 5 H).
13C NMR (CDCl3): d = 21.04t, 21.23t, 25.64t, 26.94t, 27.61t,
36.84q, 41.32s, 70.58t, 76.45d, 127.57d, 127.70d, 127.92d, 140.58.
IR (KBr): n = 3541brs, 3029m, 2934vs, 2865s, 1722w, 1669w,
1601w, 1452s, 1348vs, 1171vs, 1041s, 950vs, 838s, 705s.
1-Phenyloxaspiro[3,5]nonane (3l):37
1H NMR (CDCl3): d = 0.89-2.14 (m, 10H), 4.38 (d, 2J  = 5.6 Hz,
1 H), 4.55 (d, 2J = 5.6 Hz, 1 H), 5.46 (s, 1 H), 7.26-7.44 (m, 5 H).
13C NMR (CDCl3): d = 22.04t, 23.29t, 25.48t, 31.78t, 37.11t,
44.40s, 79.77s, 91.85d, 125.67d, 127.25d, 127.92d, 139.98s.
IR (KBr): n = 3402brw, 3061w, 3026w, 2931vs, 2854vs, 1720s,
1448s, 1271s, 1114m, 983m, 700s cm-1.
Exact mass for C14H18O requires: M, 202.136; found: M
+, 202.136.
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